Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in District of Columbia. Pick another state for the same tag.
Against expectation — 2025
District of Columbia cites F756 more often than its own record predicts
Versus expected share3.04×
3.04 times the share F756 takes of citations nationally.
Share of District of Columbia citations2.40%
Of every deficiency written in District of Columbia in 2025, this is the portion that was F756.
District of Columbia2.40%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What District of Columbia surveyors wrote
F756 findings written in District of Columbia, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedMarch 27, 2026
Based on observation, record reviews, and staff interviews, for two (2) of 33 sampled residents, the facility staff failed to ensure the licensed pharmacist conducted a monthly drug regimen review for one resident and the attending physician, or designee failed to respond to pharmacists' recommendations for one resident. Residents #6 and #26
The findings included:
1. A review of a facility policy titled 'Medication Review' with a review date of 02/11/2026 documented, in part: 6. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction